Albuterol Sulfate

DRUG14 trials

Sponsors

Milton S. Hershey Medical Center, National Heart, Lung, and Blood Institute (NHLBI), Respirics Inc., Sumitomo Pharma America, Inc., Pulmotect, Inc.

Conditions

Allergic AsthmaAsthmaAsthma in ChildrenCOPDCardiovascular System DiseaseChronic Obstructive Pulmonary Disease (COPD)Drug-Related Side Effects and Adverse ReactionsExercise Induced Bronchospasm

Phase 1

Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI

CompletedNCT00565591

Respirics Inc.Allergic Asthma

Start: 2007-11-30End: 2008-02-29Updated: 2008-02-15

Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

CompletedNCT02566252

Pulmotect, Inc.Healthy

Start: 2015-07-31End: 2016-03-31Updated: 2017-08-10

A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems

TerminatedNCT03098680

Cambridge University Hospitals NHS Foundation TrustCardiovascular System Disease, Drug-Related Side Effects and Adverse Reactions

Start: 2017-04-24End: 2020-02-29Updated: 2021-03-22

Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD

CompletedNCT03480997

Pneuma Respiratory, IncCOPD

Start: 2016-12-27End: 2017-04-28Updated: 2018-03-29

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

TerminatedNCT05035862

Emory UniversityAsthma

Start: 2022-03-16End: 2022-12-16Updated: 2025-06-03

Phase 2

Drug Study of Albuterol to Treat Acute Lung Injury

TerminatedNCT00434993

National Heart, Lung, and Blood Institute (NHLBI)Respiratory Distress Syndrome, Adult

Start: 2007-08-31End: 2008-11-30Updated: 2017-02-10

Phase 3

(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)

CompletedNCT00394329

Milton S. Hershey Medical CenterAsthma

Start: 2006-11-30End: 2011-12-31Updated: 2018-07-02

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00665600

Sumitomo Pharma America, Inc.Chronic Obstructive Pulmonary Disease (COPD)

Start: 2002-02-28End: 2003-03-31Updated: 2023-06-27

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

CompletedNCT02969408

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2017-02-13End: 2018-02-02Updated: 2021-11-09

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

RecruitingNCT06052267

Teva Branded Pharmaceutical Products R&D LLCAsthma

Start: 2023-08-30End: 2026-10-31Target: 2700Updated: 2026-04-02

Phase 4

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects

CompletedNCT00667797

Sumitomo Pharma America, Inc.Asthma, COPD

Start: 2003-03-31End: 2005-05-31Updated: 2012-02-22

Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity

TerminatedNCT03586544

University of Nevada, Las VegasAsthma in Children, Exercise Induced Bronchospasm, Obesity, Childhood

Start: 2018-09-18End: 2021-03-30Updated: 2021-07-22

Unknown Phase

Aerosolized Albuterol Use in Severe BPD

CompletedNCT02766673

Children's Hospital of PhiladelphiaSevere Bronchopulmonary Dysplasia

Start: 2016-08-31End: 2018-06-30Updated: 2019-08-28

Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal Cannula

CompletedNCT03091504

Rush University Medical CenterHigh Flow Nasal Cannula

Start: 2017-09-04End: 2018-03-31Updated: 2018-04-04

Related Papers

A digital inhaler uncovering patterns of SABA use in asthma and COPD

2020-09-072 citations

Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome

Thorax2016-07-2038 citations

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial.

2011-02-14226 citations